What's happened
Outbreak of Bundibugyo Ebola is expanding in the DRC. Doses of experimental MBP134 are being provided for compassionate use and trials are being planned with WHO leadership; several vaccine candidates are advancing in development, with primeras trials expected in months.
What's behind the headline?
Analysis
- The story shows rapid mobilization around experimental therapies and vaccines, with WHO, BARDA, and major firms coordinating across borders.
- Trials are being prioritized for urgent testing while ensuring access after trials if safe and effective.
- Expect delays due to conflict areas, supply chain disruption, and trust issues with health workers, but progress on MBP134, remdesivir, and vaccine candidates could accelerate response.
- Readers should watch for trial enrolment updates and regulatory decisions that could shape future outbreak management.
How we got here
The Bundibugyo strain has triggered a growing outbreak in the Democratic Republic of Congo, with hundreds of cases and deaths reported. International partners are coordinating trials and vaccine development to test safety and effectiveness, amid security and access challenges in affected regions.
Our analysis
Reuters reports on MBP134 compassionate use and planned trials; The Japan Times on vaccine candidates (rVSV, ChAdOx1, Moderna) and CEPI funding; Independent overview of candidates including rVSV and ChAdOx1 Bundibuguro, MBP134, maftivimab from Regeneron.
Go deeper
- What is the status of MBP134 trials in Congo?
- When will a vaccine candidate enter Phase 1 in humans?
- What can individuals do to support outbreak control?
More on these topics
-
World Health Organization
The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency's governing structure and principles, states its main objective as "the attainment
-
Uganda - Country in East Africa
Uganda, officially the Republic of Uganda, is a landlocked country in East-Central Africa. It is bordered to the east by Kenya, to the north by South Sudan, to the west by the Democratic Republic of the Congo, to the south-west by Rwanda, and to the south
-
University of Oxford - University in Oxford, England
The University of Oxford is a collegiate research university in Oxford, England. There is evidence of teaching as early as 1096, making it the oldest university in the English-speaking world and the world's second-oldest university in continuous operation
-
Remdesivir - Medication
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein.
-
Democratic Republic of the Congo - Country in Central Africa
The Democratic Republic of the Congo, also known as Congo-Kinshasa, Zaire, DR Congo, DRC, the DROC, or simply the Congo, is a country located in Central Africa. It was formerly called Zaire.
-
Gilead Sciences - Biotechnology company
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs.